ACTINIUM PHARMACEUTICALS, INC. Increase (Decrease) in Accounts Receivable, Related Parties
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Increase (Decrease) in Accounts Receivable, Related Parties of $5.87 thousand for the 157-month period ending 2013-06-30, per its 10-Q filed 2013-08-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivableRelatedParties · last filed 2014-02-28
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2012-06-30 was -$1.00.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for the quarter ending 2012-03-31 was -$50.07K.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for fiscal 2012 was -$234.09K.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in accounts receivable, related parties for fiscal 2011 was -$41.57K.
| Period end | Increase (Decrease) in Accounts Receivable, Related Parties 3 month | Increase (Decrease) in Accounts Receivable, Related Parties 6 month | Increase (Decrease) in Accounts Receivable, Related Parties 12 month | Increase (Decrease) in Accounts Receivable, Related Parties 151 month | Increase (Decrease) in Accounts Receivable, Related Parties 157 month |
|---|---|---|---|---|---|
| 2013-06-30 | $2.13K 10-Q · filed 2013-08-13 | $5.87K 10-Q · filed 2013-08-13 | |||
| 2012-12-31 | -$234.09K 10-K · filed 2014-02-28 | $3.75K 10-K · filed 2013-03-29 | |||
| 2012-06-30 | -$1.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$50.07K 10-Q · filed 2013-08-13 | |||
| 2012-03-31 | -$50.07K 10-Q · filed 2013-05-15 | ||||
| 2011-12-31 | -$41.57K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |